Switching to the anti-interleukin-6 receptor antibody tocilizumab in rheumatoid arthritis patients refractory to antitumor necrosis factor biologics - Kawashiri, Shin-ya; Kawakami, Atsushi; Iwamoto, Naoki; Fujikawa, Keita; Aramaki, Toshiyuki; Tamai, Mami; Arima, Kazuhiko; Ichinose, Kunihiro; Kamachi, Makoto; Yamasaki, Satoshi; Nakamura, Hideki; Origuchi, Tomoki; et al. (Modern rheumatology, 2010)
Keywords: DAS28; Rheumatoid arthritis; TNF antagonist; Tocilizumab; Tuberculosis